Priority review
Madrigalās NASH drug gets fast-track review from FDA, no panel needed
Anika Sharma
In the wake of a recent CEO transition, Madrigal Pharmaceuticals has disclosed that its nonalcoholic steatohepatitis (NASH) drug has been ...
FDA Awards Priority Review for Full Approval of Tarpeyo in Treating IgA Nephropathy
Anika Sharma
Calliditas Therapeutics, a leading pharmaceutical company, has exciting news to share. The U.S. Food and Drug Administration (FDA) has accepted ...
FDA Grants Priority Review for Bluebird Bio’s Sickle Cell Treatment
SG Tylor
Source – bluebird bio On June 21, 2023, the US Food and Drug Administration (FDA) accepted the Biologics Licence Application ...
